STRAINS is dedicated to structural analysis of civil structures and edifices, and innovation through research and software development, on collaboration with universities and research centers, public or private. Our clients are Engineering firms looking for high level analyses, as well as public administrations or contractors.
Location: France, Ile-de-France
Employees: 1-10
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | IT-Transla... | it-transla... |
Mentions in press and media 2
| Date | Title | Description |
| 09.11.2012 | Universal flu vaccine that could improve response to deadlier strains raises $26M | The company’s lead treatment is expected to enter clinical development in the next two years. The investment will be used to develop the company’s technology platform and advance its infectious disease pipeline. Earlier this fall the Cambri... |
| - | Universal flu vaccine that could improve response to deadlier strains raises $26M | At this time of year, notifications of free flu vaccines are as plentiful as leaves on the ground and pre-Christmas sales. But a biotechnology company is developing a monoclonal antibody for a universal flu vaccine that could not only cover... |